To: [HCP email]
From: [Field Representative email]
Subject: Invitation to Join the National Bispecifics Operational National Broadcast

Register today

Dear {{customText[Dr.|Mr.|Ms.|Mrs.| ]}} {{accLname}},

Mark your calendars! The Bispecifics Operational National Broadcast is coming up soon, and you won't want to miss it. Join us as [KOL name and affiliation] shares insights on key considerations for successfully using bispecific therapies for patients with relapsed or refractory multiple myeloma (RRMM). The broadcast will explore the three key areas of readiness that are crucial for successful treatment: facility readiness, provider and care team readiness, and patient and care partner readiness.

REGISTER HERE

Sincerely,
Oncology Specialist: {{userName}}
{{userEmailAddress}}
{{User.MobilePhone}}

Confidentiality Notice: This email transmission may contain confidential or legally privileged information that is intended only for the individual or entity named in the email address. If you are not the intended recipient, you are hereby notified that any disclosure, copying, distribution, or reliance upon the contents of this email is strictly prohibited. If you have received this email transmission in error, please reply to the sender, so that we can arrange for proper delivery, and then please delete the message from your inbox.

Third-party trademarks used herein are trademarks of their respective owners.

800 Ridgeview Drive
Horsham, PA 19044
© Janssen Biotech, Inc. 2024
06/24 cp-461032v1

If you have any questions about the information in this message,
please do not hesitate to contact me.

If you do not wish to receive further messages from me, click here to unsubscribe.

You can manage your subscription preferences here.

Please click to read our Privacy Policy.

cp-383304v1